Immunotoxicity of 2',3'-dideoxyinosine in female B6C3F1 mice (Q23915942)

2

J A

McCay

1 reference

20 October 2023

Ronnetta D. Brown

3

R D

Brown

1 reference

20 October 2023

Deborah L. Musgrove

4

D L

Musgrove

1 reference

20 October 2023

Leon F. Butterworth

6

L F

Butterworth

1 reference

20 October 2023

Susan Wilson

7

S

Wilson

1 reference

20 October 2023

Kimber L. White

8

K L Jr

White

1 reference

20 October 2023

Albert E. Munson

9

A E

Drug and Chemical Toxicology

Munson

1 reference

20 October 2023

language of work or name

1 reference

January 1997

0 references

published in

0 references

volume

20

0 references

issue

3

0 references

page(s)

189-228

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

cites work

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.3109/01480549709003878

DNA sequencing with chain-terminating inhibitors

20 April 2017

1 reference

https://api.crossref.org/works/10.3109/01480549709003878

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

20 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Effects of 2?,3?-dideoxynucleosides on mammalian cells and viruses

20 April 2017

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

The B lymphocyte is the immune cell target for 2',3'-dideoxyadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program's guidelines for immunotoxicity evaluation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Immunotoxicity of the semiconductor gallium arsenide in female B6C3F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Comparison of ELISA and plaque-forming cell assays for measuring the humoral immune response to SRBC in rats and mice treated with benzo[a]pyrene or cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

An immunotoxicological evaluation of 4,4'-thiobis-(6-t-butyl-m-cresol) in female B6C3F1 mice. 2. Humoral and cell-mediated immunity, macrophage function, and host resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Extrapolation of animal toxicity to humans: interspecies comparisons in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Immunocytochemical and morphometric analysis of acinar zymogen granules in human acute pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Disruption of mitochondrial energetics and DNA synthesis by the anti-AIDS drug dideoxyinosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Use of Ranks in One-Criterion Variance Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

A Multiple Comparison Procedure for Comparing Several Treatments with a Control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.3109%2F01480549709003878